Dixon Technologies (India) Ltd
NSE: DIXONCompany page on Cofacto
Open the Dixon Technologies (India) Ltd page

Dixon Technologies Q2 FY27 Results Analysis: Revenue Jumps 47%, Margin Compresses 76 bps

Cofacto Research Published October 30, 2026 3 min read
Neutral

Dixon Technologies (India) Ltd's Q2 FY27 numbers came in mixed, with revenue of Rs. 21,793.64 Cr (+46.71% YoY) and PAT growth of -44.90% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateOctober 30, 2026
Revenue (Q2)Rs. 21,793.64 Cr (+46.71% YoY)
PAT (Q2)Rs. 410.87 Cr (-44.90% YoY)
EBITDA margin2.11% (-76 bps YoY)
EPS (Q2)Rs. 67.44 (-45.44% YoY)

Quarter Snapshot

Revenue grew 46.71% YoY to Rs.21,793.64 crore with normalized PAT up 18.16% YoY once prior-year one-off gains are stripped, but the clean operating margin of 2.11% is down 76 bps YoY. H1 operating cash flow was negative Rs.280.02 crore and the Rs.1,110.06 crore PLI receivable remains unresolved with auditor emphasis of matter. No quantified management guidance exists in the filing, so no guidance beat or miss can be established.

Q2 FY27 Expectations vs Results

DriverExpected before resultsWhat happenedVerdict
Revenue"revenue looks ahead YoY if the guided volume ramp held" — share gains against a −26% handset marketRs.21,793.64 crore, +46.71% YoY, +40.17% QoQPlayed out
Margins"margins likely flat to compressing… thin conversion margin, PLI/other-income dependence persisting"Ex-OI margin 2.11% vs 2.14% Q1, 2.87% prior-year Q2Played out
PLI receivable"Rs.1,110.06 Cr outstanding pending formal determination — the key cash-conversion overhang"Note 6 confirms receivable still outstanding; amount booked in the quarter not disclosed; H1 CFO −Rs.280.02 crorePlayed out
Mobile volumes vs 9–9.2m guidedVolume test of share gainsNot disclosed in the filing — open for the callNot observable
Memory-cost pass-through"how much of the chip-price spike flowed into customer-specified BOM pricing"Materials ratio improved to 94.89% from 96.89% QoQ but no BOM-mix disclosurePartially observable
Vivo JV / display ramp from Q3"Q2 remains a pre-JV quarter"New 51% subsidiary incorporated; no JV revenue detail — consistentNot observable
US tariff overhang"the tariff overhang has so far not dented the export lane"Not addressed in the filing — remains open for the callNot observable

Read our full results preview.

Management Guidance vs Delivery

What management saidWhereWhat happenedVerdict
~32m phones FY27Q1 FY27 earnings call (per pre-call note)Not disclosedToo Early
Margin pressure to continue through FY27Q1 FY27 management commentary (per pre-call note)Operating EBITDA margin ex-other income 2.11% vs 2.87% prior-year Q2, 2.14% Q1Confirmed as a directional claim

Key Investment Insights

Key Positives

  • Consolidated revenue grew 46.71% YoY and 40.17% QoQ to Rs.21,793.64 crore; H1 revenue of Rs.37,341.30 crore is up 34.85% YoY
  • Normalized PAT grew 18.16% YoY to Rs.410.87 crore after stripping Rs.492.92 crore of prior-year investment/slump-sale gains
  • Operating EBITDA ex-other income grew 38.78% QoQ and 7.99% YoY to Rs.460.81 crore
  • Materials ratio improved to 94.89% of revenue from 96.89% in Q1 FY27
  • Employee costs grew only 9.55% YoY and other expenses declined 1.10% YoY against 46.71% revenue growth
  • Finance costs fell 32.33% YoY to Rs.25.95 crore; net debt of Rs.167.52 crore is modest against Rs.6,728.43 crore of equity
  • Inventory days of 29.2 are essentially unchanged from FY26's 28.7, indicating the inventory build tracks the revenue run-rate

Risk Factors

  • H1 operating cash flow was negative Rs.280.02 crore (vs +Rs.880.84 crore in H1 FY26) with FCF of −Rs.986.94 crore
  • Rs.1,110.06 crore PLI receivable remains outstanding pending formal determination, flagged in the auditors' emphasis-of-matter paragraph
  • Operating EBITDA margin ex-other income compressed 76 bps YoY to 2.11% from 2.87%
  • Effective tax rate rose to 22.82% from 17.39% in Q1 and 19.26% in the prior-year quarter
  • Reported consolidated PAT fell 44.90% YoY and standalone PAT fell 74.20% YoY
  • NCI share of Q2 PAT rose to 16.36% from 10.15% a year ago, reducing profit accrual to owners
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now